UltraSPECT, a leading provider of image reconstruction technology that reduces radiopharmaceutical dose and acquisition time for nuclear medicine (NM) exams, announces today that study data has shown UltraSPECT solutions are a viable method for meeting American Society of Nuclear Cardiology (ASNC) low dose guidelines. Furthermore, technologists are able to rely on their existing imaging protocols, providing added confidence in overall results. UltraSPECT will be demonstrating this solution to conference attendees at the upcoming ASNC Annual Meeting, September 26-29, in Chicago.

Triad Isotopes, Inc. (Triad) has announced the addition of two nationally-recognized executives to the company’s leadership team.  Kerry E. Gillespie, CPA, CGMA has joined the company as Chief Financial Officer (CFO) and Chief Operations Officer (COO).  Douglas Ash has joined the company as Chief Information Officer (CIO).  Both report to Dom Meffe, President & Chief Executive Officer (CEO).

AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the enrollment of the first patient at University of Miami Hospital in a randomized multi-center study investigating whether the BioFlo PICC will be associated with a reduced incidence of catheter-related venous thrombosis, including both symptomatic and asymptomatic, compared to another commercially available PICC, the Bard PowerPICC SOLO2.

Phytel, the leader in automated, provider-led population health improvement, has been selected to demonstrate its advanced care management technology at the upcoming Health 2.0 conference, which will take place October 7-11 at the Santa Clara Convention Center in Santa Clara, Calif.

Evaluating myocardial blood flow (MBF) with stress-rest cardiac PET teases out more multivessel CAD than with cardiac PET or SPECT alone, both of which tend to underestimate severity of disease, according the proceedings of the 2013 American Society of Nuclear Cardiology (ASNC) 2013 Annual Meeting held Sept. 26-29 in Chicago.

Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene.

On the heels of the final decision from CMS regarding coverage for amyloid imaging, Peter Herscovitch, MD, SNMMI 2013-2014 president elect, discussed the potential impact of the new climate of coverage in an exclusive interview with Molecular Imaging.

The National Football League (NFL) attempted to downplay the risks of playing football and tried to influence concussion research, according to bombshell allegations in a new book, “League of Denial: The NFL, Concussions and the Battle for Truth.”